- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04892602
Fibromyalgia in Rheumatiod and Psoriatic Patients
March 29, 2022 updated by: Alshimaa Hamdey Khalaf, Sohag University
Fibromyalgia in Rheumatiod and Psoriatic Arthritis Patients:Relationshipwith Disease Activity and Serum Vitamin Dlevel
the study based on investigate for fibromyalgia among rheumatiod arthritis patient and psoriatic arthritis.....and to what extent gibromyalgia affect disease activity indices ....and its relation to serum Vitamin D level in those patients
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
130
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sohag, Egypt
- Sohag University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Those patient who diagnosed as rheumatiod arthritis and psoriatic arthritis..assess serum vitamin D level
Description
Inclusion Criteria:
- adult onset disease any patient diagnosed as rheumatiod arthritis and psoriatic arthritis above18years old
Exclusion Criteria:
- any other autoimmune diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Control group
|
Investigate about fibromyalgia in psoiaritic and rheumatiod arthritis patients ...and assesment of seum vitamin D level
|
Rheumatiod arthritis patients
|
Investigate about fibromyalgia in psoiaritic and rheumatiod arthritis patients ...and assesment of seum vitamin D level
|
Psoaritic arthritis
|
Investigate about fibromyalgia in psoiaritic and rheumatiod arthritis patients ...and assesment of seum vitamin D level
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum vitamin D level
Time Frame: One year
|
Blood test to asses hypovitaminosis in these patients
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2021
Primary Completion (Actual)
March 1, 2022
Study Completion (Actual)
March 1, 2022
Study Registration Dates
First Submitted
May 16, 2021
First Submitted That Met QC Criteria
May 16, 2021
First Posted (Actual)
May 19, 2021
Study Record Updates
Last Update Posted (Actual)
April 7, 2022
Last Update Submitted That Met QC Criteria
March 29, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med-21-05-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Serum Vitamin Dlevel Disease activity indice
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia, Secondary
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Gaziosmanpasa Research and Education HospitalCompleted
-
Hospital of South West JutlandRecruitingFatigue | Rheumatoid Arthritis | Physical Inactivity | Fibromyalgia, SecondaryDenmark
-
Ahi Evran University Education and Research HospitalCompletedRheumatoid Arthritis | Fibromyalgia | Fibromyalgia, SecondaryTurkey
-
Hospital of South West JutlandOdense University HospitalRecruitingRheumatoid Arthritis | Widespread Chronic Pain | Fibromyalgia, Secondary | Muscle DisorderDenmark
-
The Second Hospital of Nanjing Medical UniversityRecruitingSecondary Hyperparathyroidism;ParathyroidectomyChina
-
Chang Gung Memorial HospitalCompletedSecondary Hyperparathyroidism Due to Renal CausesTaiwan
-
Fundación SenefroAbbVie; Effice Servicios Para la Investigacion S.L.CompletedSecondary Hyperparathyroidism Due to Renal CausesSpain
-
Phramongkutklao College of Medicine and HospitalCompletedAlfacalcidol, Secondary Hyperparathyroidism, Hemodialysis
Clinical Trials on Serum vitaminDlevel
-
Pontificia Universidad Catolica de ChileHospital Dr Sotero del RioUnknownDry Eye | Keratoconjunctivitis Sicca | Lacrimal Apparatus Diseases | Conjunctival Diseases | Keratitis | Corneal Diseases | Sjogren's SyndromeChile
-
Assiut UniversityUnknownCardiotoxicity | Aluminum Phosphid PoisoningEgypt
-
Laboratorios de Biologicos y Reactivos de México...Completed
-
Ankara Etlik City HospitalDiskapi Yildirim Beyazit Education and Research HospitalCompleted
-
Santalis Pharmaceuticals, Inc.Derm Research, PLLC; ClinDatrix, Inc.; Clinical Trials of Texas, Inc.; Progressive... and other collaboratorsCompletedPlaque PsoriasisUnited States
-
Sohag UniversitySohag General HospitalNot yet recruiting
-
Laboratorios de Biologicos y Reactivos de México...Completed
-
Sohag UniversityNot yet recruiting
-
Algenis SpAOncoclínicasRecruitingChemotherapy-induced Peripheral NeuropathyBrazil